In the case of Krabbe disease, current data shows that the false positive rate would be lower if the biomarker psychosine was measured as a first-tier test compared to measurement of the activity of the relevant enzyme galactocerebrosidase (GALC) (Section 6.4 below). Here, GALC is linked to Krabbe disease.